RPTX Financials

Repare Therapeutics Inc - Financial statements & key metrics

Stock Price

$0.00

Market Cap

$61.76M

EPS

$-1.70

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-84.69M

EPS (Diluted)

$-2.00

Balance Sheet Highlights

Total Assets

$176.51M

Total Liabilities

$25.38M

Shareholders Equity

Cash & Equivalents

$84.72M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-76.44M

CapEx

Free Cash Flow

Profitability Metrics

Operating Margin

-3.7%

ROE

-49.8%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is RPTX revenue?

View RPTX's income statement for detailed revenue data.

Is RPTX profitable?

RPTX reported a loss of $84.69M in the most recent quarter.

What is RPTX market cap?

RPTX has a market capitalization of $61.76M, making it a small-cap stock.

Does RPTX have debt?

View RPTX's balance sheet for debt information.

What is RPTX cash flow?

Cash flow data is available in the full financial statements.